Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-26

Clinical Trial Update: "Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness" [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a preservative-free brimonidine tartrate formulation for ocular redness in adults has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine Tartrate Preservative-Free Formulation (brimonidine tartrate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Ocular Redness | Phase 3 | Status: COMPLETED | Results posted: 2024-08-26